Growth Metrics

Profound Medical (PROF) Equity Ratio (2018 - 2026)

Profound Medical has reported Equity Ratio over the past 8 years, most recently at 0.86 for Q4 2025.

  • For Q4 2025, Equity Ratio changed 0.33% year-over-year to 0.86; the TTM value through Dec 2025 reached 0.86, changed 0.33%, while the annual FY2025 figure was 0.86, 0.33% changed from the prior year.
  • Equity Ratio for Q4 2025 was 0.86 at Profound Medical, up from 0.76 in the prior quarter.
  • Over five years, Equity Ratio peaked at 927622.89 in Q1 2022 and troughed at 0.71 in Q4 2023.
  • A 5-year average of 90706.02 and a median of 0.83 in 2025 define the central range for Equity Ratio.
  • On a YoY basis, Equity Ratio climbed as much as 21.11% in 2024 and fell as far as 100.0% in 2024.
  • Year by year, Equity Ratio stood at 0.93 in 2021, then dropped by 12.12% to 0.82 in 2022, then decreased by 13.0% to 0.71 in 2023, then increased by 21.11% to 0.86 in 2024, then fell by 0.33% to 0.86 in 2025.
  • Business Quant data shows Equity Ratio for PROF at 0.86 in Q4 2025, 0.76 in Q3 2025, and 0.79 in Q2 2025.